Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase
复制标题
发现和开发靶向烯酰基载体蛋白还原酶的新型绕丹宁衍生物
DOI:
10.1016/j.bmc.2019.02.043
复制
发表时间:
2019
影响因子:
3.5
通讯作者:
Hai-Liang Zhu
中科院分区:
文献类型:
--
作者:
Jian-Fei Xu;Tian-Tian Wang;Qing Yuan;Yong-Tao Duan;Yun-Jie Xu;Peng-Cheng Lv;Xiao-Ming Wang;Yu-Shun Yang;Hai-Liang Zhu
A series of rhodanine derivatives RB1–RB23 were synthesized through a two-round screening. Their Mycobacterial tuberculosis (Mtb) InhA inhibitory activity and Mtb growth blocking capability were evaluated. The most potent hit compound RB23 indicated comparable InhA inhibiton (IC50 = 2.55 μM) with the positive control Triclosan (IC50 = 6.14 μM) and Isoniazid (IC50 = 8.29 μM). Its improved growth-blocking effect on Mtb and low toxicity were attractive for further development. The docking simulation revealed the possible binding pattern of this series and picked the key interacted residues as Ser20, Phe149, Lys165 and Thr196. The 3D-QSAR model visualized the SAR discussion and hinted new information. Modifying the surroundings near rhodanine moiety might be promising attempts in later investigations.